Skip to search formSkip to main contentSkip to account menu

benfluorex

Known as: Benfluorexum, 1-(3-trifluoromethylphenyl)-2-[N-(2-benzoyloxyethyl)amino]propane, benfluramate 
An antilipidemic agent that decreases the relative rate of hepatic triacylglycerol synthesis. Benfluorex was never approved for use in the United… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Department of Cardiology, University Hospital Brest, Brest, France; Department of Cardiology, University Hospital Amiens, Amiens… 
1993
1993
OBJECTIVE To evaluate the change in lipids and insulin sensitivity in 10 obese type II diabetic patients after treatment with… 
1993
1993
Benfluorex is a hypolipidaemic agent with biguanide-like properties. To evaluate its blood glucose lowering action, a single… 
1989
1989
L'administration de benfluorex pendant 3 mois chez des diabetiques (type II) soumis a un regime alimentaire permettant de… 
1989
1989
In this study, 16 overweight or obese NIDDM patients with a long period of stable weight and dietary surveillance were treated… 
1986
1986
The hypocholesterolaemic drug Benfluorex has been shown to inhibit the rate of sterol synthesis in rat hepatocytes. At present no… 
1978
1978
Rats were treated chronically with various anorexigenic substances which were administered orally once (or twice) daily or… 
1977
1977
Rats were treated for 5 days with benfluorex [1-(3-trifluoromethylphenyl)-2-[N-(2-benzoyloxyethyl)amino]propane] or with… 
Highly Cited
1975
Highly Cited
1975
The effects on glycerolipid synthesis of a series of compounds including many drugs were investigated in cell-free preparations… 
1973
1973
1. Owing to a (3)H isotope effect, the mitochondrial sn-glycerol 3-phosphate oxidase (EC 1.1.99.5) had a mean activity which was…